Cargando…

In Patients Hospitalized for Community-Acquired Pneumonia, SARS-CoV-2 Is Associated with Worse Clinical Outcomes When Compared to Influenza

SARS-CoV-2 and influenza are primary causes of viral community-acquired pneumonia (CAP). Both pathogens have exhibited high transmissibility and are recognized causes of pandemics. Controversy still exists regarding the clinical outcomes between patients hospitalized with CAP due to these viruses. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spindel, Jeffrey, Furmanek, Stephen, Chandler, Thomas, Ramirez, Julio A., Cavallazzi, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142714/ https://www.ncbi.nlm.nih.gov/pubmed/37111457 http://dx.doi.org/10.3390/pathogens12040571

Ejemplares similares

Pneumonia Severity Index and CURB-65 Score Are Good Predictors of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Bradley, James, et al.
Publicado: (2022)

Clinical outcomes in patients with COPD hospitalized with SARS-CoV-2 versus non- SARS-CoV-2 community-acquired pneumonia
por: Sheikh, Daniya, et al.
Publicado: (2022)

Cardiovascular Complications Are the Primary Drivers of Mortality in Hospitalized Patients With SARS-CoV-2 Community-Acquired Pneumonia
por: Ali, Ahmed Shebl, et al.
Publicado: (2023)

Association between body mass index and mortality in hospitalised patients with community-acquired pneumonia
por: Kim, Richard Y., et al.
Publicado: (2021)

Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2023)

2110. Immunocompromised Adults Hospitalized with Community-Acquired Pneumonia in the United States: Incidence and Clinical Outcomes
por: Ramirez, Julio A, et al.
Publicado: (2022)

Influenza and Viral Pneumonia
por: Cavallazzi, Rodrigo, et al.
Publicado: (2018)

23-Valent Pneumococcal Polysaccharide Vaccination Does Not Prevent Community-Acquired Pneumonia Hospitalizations Due to Vaccine-Type Streptococcus pneumoniae
por: Chandler, Thomas, et al.
Publicado: (2022)

Adjunctive immunomodulation in severe community-acquired pneumonia
por: Bradley, James, et al.
Publicado: (2023)

Viral infection in community-acquired pneumonia: a systematic review and meta-analysis
por: Burk, Michael, et al.
Publicado: (2016)

2195. Incidence of Acute Myocardial Infarction in Patients with Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Nieto Dominguez, Alejandro, et al.
Publicado: (2019)

Response
por: Chandler, Thomas R., et al.
Publicado: (2023)

How and when to manage respiratory infections out of hospital
por: Cavallazzi, Rodrigo, et al.
Publicado: (2022)

Acute Respiratory Distress Syndrome and Time to Weaning Off the Invasive Mechanical Ventilator among Patients with COVID-19 Pneumonia
por: Bordon, Jose, et al.
Publicado: (2021)

Epidemiology of Pneumococcal Pneumonia in Louisville, Kentucky, and Its Estimated Burden of Disease in the United States
por: Ramirez, Julio, et al.
Publicado: (2023)

Contrasting Inflammatory Responses in Severe and Non-severe Community-acquired Pneumonia
por: Fernandez-Botran, Rafael, et al.
Publicado: (2014)

Clinical Outcomes of Immunocompromised Adults Hospitalized with Pneumococcal Pneumonia: A Case-Control Study
por: Ramirez, Julio, et al.
Publicado: (2021)

The upper respiratory tract microbiome of hospitalised patients with community-acquired pneumonia of unknown aetiology: a pilot study
por: Wiemken, Timothy L., et al.
Publicado: (2015)

Processes of care for community-acquired pneumonia
por: Ramírez, Julio A.
Publicado: (2004)

Ventilator-associated pneumonia is linked to a worse prognosis than community-acquired pneumonia in children
por: Hernandez-Garcia, Maria, et al.
Publicado: (2022)

Discovery and predictive modeling of urine microbiome, metabolite and cytokine biomarkers in hospitalized patients with community acquired pneumonia
por: Pierre, Joseph F., et al.
Publicado: (2020)

Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia?
por: Vallecoccia, Maria Sole, et al.
Publicado: (2020)

How and when to use common biomarkers in community-acquired pneumonia
por: Shaddock, Erica J.
Publicado: (2016)

Bacterial co-infections in community-acquired pneumonia caused by SARS-CoV-2, influenza virus and respiratory syncytial virus
por: Hedberg, Pontus, et al.
Publicado: (2022)

Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies
por: Ramirez, Julio A., et al.
Publicado: (2020)

Influenza C virus–associated community‐acquired pneumonia in children
por: Principi, Nicola, et al.
Publicado: (2012)

A review of the role of Haemophilus influenzae in community-acquired pneumonia
por: Slack, Mary P. E.
Publicado: (2015)

Etiology and characteristics of community-acquired pneumonia in an influenza epidemic period
por: Lin, Chun, et al.
Publicado: (2019)

Burden of Community-Acquired Pneumonia due to PCV-13 Streptococcus pneumoniae Serotypes Among Hospitalized Adults in the United States
por: Ramirez, Julio
Publicado: (2017)

Cardiovascular Complications Are the Executioners of Inpatient With SARS-CoV-2 Community-Acquired Pneumonia
por: Zeng, Guangting
Publicado: (2023)

What is the Role of Respiratory Viruses in Community-Acquired Pneumonia?: What is the Best Therapy for Influenza and Other Viral Causes of Community-Acquired Pneumonia?
por: Pavia, Andrew T.
Publicado: (2013)

Community-Acquired Pneumonia due to Streptococcus pneumoniae: When to Consider Coinfection with Active Pulmonary Tuberculosis
por: Garcia, Ruslan
Publicado: (2019)

Severe Community-acquired Pneumonia Due to Staphylococcus aureus, 2003–04 Influenza Season
por: Hageman, Jeffrey C., et al.
Publicado: (2006)

Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

The Role of Biomarkers in Influenza and COVID-19 Community-Acquired Pneumonia in Adults
por: Carbonell, Raquel, et al.
Publicado: (2023)

COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia
por: Zhou, Yutian, et al.
Publicado: (2020)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d3k0bba8cdk1l56klvla2j3qbe